Staphylococcus aureus nasal carriage and associated factors in type 2 diabetic patients

dc.authorid0000-0003-1514-1685en_US
dc.authorid0000-0003-2005-0737en_US
dc.authorid0000-0003-0064-3893
dc.contributor.authorTamer, Ali
dc.contributor.authorKarabay, Oğuz
dc.contributor.authorEkerbiçer, Hasan
dc.date.accessioned2021-06-23T19:19:23Z
dc.date.available2021-06-23T19:19:23Z
dc.date.issued2006
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractWe aimed to compare the rate of nasal carriage of Staphylococcus aureus (NCSA) between type 2 diabetic patients and non-diabetic ones and also to reveal the associated risk factors. Type 2 diabetic subjects were selected from outpatient diabetes clinics and control subjects were selected from outpatient internal medicine clinics in the same hospital. The subjects were divided into 3 groups. Group I included 68 subjects on insulin therapy and dietetic treatment, Group II included 80 subjects on oral anti-diabetic agents and dietetic treatment and Group III included 150 age- and sex-matched non-diabetic subjects. The rates of NCSA for Group I, II and III subjects were found to be 24 (35.3%), 11 (13.8%), and 16 (10.7%), respectively. Whereas there was no significant difference in NCSA positivity between Group II and Group III, a significant difference was found between Groups I and III (P <0.01). Univariate analysis revealed that the following were significant risk factors for NCSA in our diabetic patients: insulin use, hospital admission within the last 6 months, being diabetic for more than 6 years, fasting glucose level above III mg/dl and antibiotic usage within the last 6 months. Furthermore, insulin use (odds ratio 3.32) and antibiotic usage within the last 6 months (odds ratio 5.75) were defined as significant risk factors for NCSA in diabetic subjects by the logistic regression method. Our results suggested that the rate of NCSA was significantly higher in type 2 diabetic patients who used insulin or antibiotics within the last 6 months.en_US
dc.identifier.endpage14en_US
dc.identifier.issn1344-6304
dc.identifier.issn1884-2836
dc.identifier.issue1en_US
dc.identifier.pmid16495627en_US
dc.identifier.scopus2-s2.0-33644529132en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage10en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12491/5930
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-33644529132&partnerID=40&md5=55196bf1650191e57ec7d87e884a0680
dc.identifier.volume59en_US
dc.identifier.wosWOS:000235785000003en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorTamer, Ali
dc.institutionauthorKarabay, Oğuz
dc.language.isoenen_US
dc.publisherNatl Inst Infectious Diseasesen_US
dc.relation.ispartofJapanese Journal Of Infectious Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectType 2en_US
dc.subjectNasal Cavity
dc.subjectStaphylococcus Aureus
dc.subjectCotrimoxazole
dc.titleStaphylococcus aureus nasal carriage and associated factors in type 2 diabetic patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
ali-tamer.pdf
Boyut:
67.99 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/ Full text